Paper42010558
mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges.
Liu Y and 6 others. J Nanobiotechnology, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges. Papers, record 42010558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42010558
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sepsis | Major topic |
| RNA, Messenger | Major topic |
| Humans | |
| Animals | |
| Nanoparticles | |
| Nanomedicine | |
| Immunomodulation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82002096 | National Natural Science Foundation of China | PubMed | ||
| 82002101 | National Natural Science Foundation of China | PubMed | ||
| 2023AFB825 | Natural Science Foundation of Hubei Province | PubMed | ||
| 2023A15 | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | PubMed |
Source PubMed
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40021827 | High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics. | Nat Mater | 2025 | https://conductscience.org/library/papers/40021827 | PubMed |
| 2 | 34705481 | Sepsis-Induced Immunosuppression. | Annu Rev Physiol | 2022 | https://conductscience.org/library/papers/34705481 | PubMed |
| 3 | 38169577 | Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. | Theranostics | 2024 | https://conductscience.org/library/papers/38169577 | PubMed |
| 4 | 38496165 | Navigating the Cytokine Storm: A Comprehensive Review of Chemokines and Cytokines in Sepsis. | Cureus | 2024 | https://conductscience.org/library/papers/38496165 | PubMed |
| 5 | 29935173 | Nucleic-acid based gene therapy approaches for sepsis. | Eur J Pharmacol | 2018 | https://conductscience.org/library/papers/29935173 | PubMed |
| 6 | 40829705 | Nanoparticle-based approaches for sepsis treatment: Current trends and perspectives. | J Control Release | 2025 | https://conductscience.org/library/papers/40829705 | PubMed |
| 7 | 34356636 | Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis. | Biomolecules | 2021 | https://conductscience.org/library/papers/34356636 | PubMed |
| 8 | 37301780 | Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/37301780 | PubMed |
| 9 | 38235403 | Enrichment of nano delivery platforms for mRNA-based nanotherapeutics. | Med Rev (2021) | 2023 | https://conductscience.org/library/papers/38235403 | PubMed |
| 10 | 35342149 | Developing mRNA for Therapy. | Keio J Med | 2022 | https://conductscience.org/library/papers/35342149 | PubMed |
| 11 | 34332771 | From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases. | Mol Aspects Med | 2021 | https://conductscience.org/library/papers/34332771 | PubMed |
| 12 | 37603859 | The Calm after the Storm: Implications of Sepsis Immunoparalysis on Host Immunity. | J Immunol | 2023 | https://conductscience.org/library/papers/37603859 | PubMed |
| 13 | 37914340 | [Albumin-based Drug Delivery System Targeting Mannose Receptors and Its Application to Medical Treatments]. | Yakugaku Zasshi | 2023 | https://conductscience.org/library/papers/37914340 | PubMed |
| 14 | 34758337 | The immunology of sepsis. | Immunity | 2021 | https://conductscience.org/library/papers/34758337 | PubMed |
| 15 | 34651652 | The pathophysiology of sepsis - 2021 update: Part 2, organ dysfunction and assessment. | Am J Health Syst Pharm | 2022 | https://conductscience.org/library/papers/34651652 | PubMed |
| 16 | 34443638 | Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis. | Molecules | 2021 | https://conductscience.org/library/papers/34443638 | PubMed |
| 17 | 34811367 | A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. | Nat Commun | 2021 | https://conductscience.org/library/papers/34811367 | PubMed |
| 18 | 30994733 | Sepsis: evolving concepts and challenges. | Braz J Med Biol Res | 2019 | https://conductscience.org/library/papers/30994733 | PubMed |
| 19 | 38528828 | mRNA vaccine designs for optimal adjuvanticity and delivery. | RNA Biol | 2024 | https://conductscience.org/library/papers/38528828 | PubMed |
| 20 | 39063011 | From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39063011 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723083 | Epigenetic regulation of neutrophil dysfunction in sepsis: mechanisms, biomarkers, and translational challenges. | J Transl Med | 2026 | https://conductscience.org/library/papers/42723083 | PubMed |
| 42614594 | Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42614594 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42010558
GET https://conductscience.org/api/papers/v1/42010558/references?page=2